Compounds > 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone
Page last updated: 2024-09-03

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and Liver Steatosis

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone has been researched along with Liver Steatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaieb, L; Eikel, D; Elphick, LM; Guschina, IA; Harwood, JL; Nau, H; Pawolleck, N; Plant, NJ; Williams, RS1

Other Studies

1 other study(ies) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and Liver Steatosis

ArticleYear
Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.
    Disease models & mechanisms, 2012, Volume: 5, Issue:2

    Topics: Cell Line; Dictyostelium; Fatty Acids; Fatty Liver; Hepatocytes; Humans; Inositol; Kinetics; Lipid Metabolism; Models, Biological; Species Specificity; Teratogens; Valproic Acid

2012